Full Professor(heuristic)

Cancer Immunotherapy and Biomarkers · Oncology

Compare more Oncology professors.

h-index42
i10-index66
Publications148
Citations25,510

Grants

No NSF/NIH grants on record.

Recent Public Signals

  1. New paper: Corrigendum to “Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [JTO Clinical and Research Reports Vol. 4 No. 1: 100431] (JTO Clinical and Research Reports)2025-09-02
  2. New preprint: Supplementary Figure S2 from Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma2024-12-02

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

ORCID: 0000-0001-8120-2277

Professor Insights

Career Trajectory